Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.

Haverich, Axel; Shernan, Stanton K; Levy, Jerrold H; Chen, John C; Carrier, Michel; Taylor, Kenneth M; Van de Werf, Frans; Newman, Mark F; Adams, Peter X; Todaro, Thomas G; van der Laan, Michael; Verrier, Edward D

Haverich, Axel; Shernan, Stanton K; Levy, Jerrold H; Chen, John C; Carrier, Michel; Taylor, Kenneth M; Van de Werf, Frans; Newman, Mark F; Adams, Peter X; Todaro, Thomas G; van der Laan, Michael; Verrier, Edward D.

Affiliation

Haverich A; Hannover Medical School, Hannover, Germany. haverich@thg.mh-hannover.de

Ann Thorac Surg ; 82(2): 486-92, 2006 Aug.

Article de En | MEDLINE | ID: mdl-16863750

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pontage cardiopulmonaire / Pontage aortocoronarien / Anticorps monoclonaux / Infarctus du myocarde Type d'étude: Clinical_trials / Etiology_studies Limites: Female / Humans / Male Langue: En Journal: Ann Thorac Surg Année: 2006 Type de document: Article Pays d'affiliation: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links